About: Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована у вересні 2006 (uk) im September 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2006 (ast) scientific article published on 01 September 2006 (en)
publication date	wds:Q80203589-DDEC51A0-8BC1-40F1-A222-E0F7D8BF9ED5
publication date	2006-09-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80203589-0923457E-E6AF-4D8C-B59C-DB0BC855B84C wds:Q80203589-12A5B88D-8B53-4ED8-AEBE-BCDA2DF54EB4 wds:Q80203589-12F572E9-924A-4B6E-8147-F0EEC2FA7D37 wds:Q80203589-5656E979-3BDF-4EC2-A690-F1FB4E6719AF wds:Q80203589-8252CE7B-E980-4E86-9359-6EC7E9715D51 wds:Q80203589-97F17610-175F-4888-B480-53BE90001D9F wds:Q80203589-C65E1F29-7FF6-4320-9646-B68F861915CB
author name string	Thuluvath PJ Wong F Maheshwari A Korula J Yoo HW Parikh C Steare S
rdfs:label	Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study (en) Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study (nl)
skos:prefLabel	Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study (en) Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study (nl)
name	Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study (en) Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study (nl)
author	wds:Q80203589-CF13FE74-4F8D-4BBE-BC51-C9BB8E1855D0
author	Robert William Schrier
title	wds:Q80203589-523064C0-1A0D-4B58-8A01-4116403767AD
title	Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study (en)
page(s)	wds:Q80203589-B05CDFB8-9279-46D2-828B-740337C5FE5D
page(s)	973-982
instance of	wds:Q80203589-3B7B1A8B-35E1-4B53-AD76-4CAAEE0D5435
instance of	scholarly article
PubMed ID	wds:Q80203589-E31F9A5D-9F42-40E4-817B-0AAEFFBF5004
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16948809
PubMed ID	16948809
published in	wds:Q80203589-62172B01-101B-432B-9C3F-DEBC4C9EC8E3
published in	Alimentary Pharmacology & Therapeutics
issue	wds:Q80203589-E350F5BC-099E-4294-937E-11C6AB9A9CE8
volume	wds:Q80203589-E147490D-C180-41DA-909C-DCFB97860B0F
issue	6
volume	24
DOI	wds:Q80203589-9FF81D1B-4371-4ABB-BD55-DFC3064059A5
DOI	http://dx.doi.org/10.1111/J.1365-2036.2006.03088.X
DOI	10.1111/J.1365-2036.2006.03088.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80203589
is cites work of	Hyponatremia in cirrhosis: pathophysiology and management Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats. Pharmacology of vasopressin antagonists Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites? The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials Interventions for chronic non-hypovolaemic hypotonic hyponatraemia Treatment for cirrhosis-associated hyponatremia? Vaptans and aquaresis Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites
is cites work of	wds:Q27027861-031F7B98-6FAB-46A0-965B-4E31B2A47135 wds:Q35657152-F901CD61-D309-4A72-BEA6-5A30693BD784 wds:Q37259289-56487C6F-D4B7-4EC6-82F4-32C2D74EE775 wds:Q57689080-54C2396E-D90C-4ADF-B398-4B09EACD3DA6 wds:Q80060232-1914F4C3-AC98-4919-80D2-9554EE925793 wds:Q31166704-8F2A76AB-8C1C-4E60-8D78-E1676E2D6A4C wds:Q26778032-7CB021D0-2EC6-41A5-8469-119CE98B18E4 wds:Q35092574-3AA63A48-AB5E-49E4-9C05-3C522CA34627 wds:Q37100471-A102D06F-9DA0-4F0D-800D-E20C6182B40B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software